特应性皮炎儿童认知障碍症状的关联研究
该横断面研究基于2021年美国国家健康访谈调查数据,纳入17岁及以下无智力障碍或自闭症的儿童,分析特应性皮炎(AD)与学习或记忆困难症状的关联。结果显示AD儿童报告学习困难(10.8% vs 5.9%)和记忆困难(11.1% vs 5.8%)的比例更高,调整后AD与学习困难(AOR 1.77)和记忆困难(AOR 1.69)的 odds 增加相关,但该关联主要限于合并神经发育共病的儿童。
要点
- AD儿童报告学习和记忆困难的比例显著高于无AD儿童。
- AD与学习困难(AOR 1.77)和记忆困难(AOR 1.69)的 odds 增加独立相关。
- 合并神经发育共病时AD与记忆困难的关联更强(AOR 2.26),无共病儿童中无显著关联。
核心结论
- 儿童AD总体与报告的学习和记忆困难 odds 增加相关,但关联主要限于合并神经发育共病(如ADHD或学习障碍)的儿童。
研究设计与样本
- 横断面研究,使用2021年美国国家健康访谈调查数据,纳入17岁及以下无智力障碍或自闭症的儿童,加权总人数69 732 807,其中AD 9 223 013人(13.2%)。
主要发现
- AD儿童学习困难报告率10.8%(95%CI 7.8%-15.8%),无AD儿童5.9%(95%CI 5.1%-6.9%),P < .001。
- AD儿童记忆困难报告率11.1%(95%CI 8.0%-15.9%),无AD儿童5.8%(95%CI 4.9%-6.9%),P < .001。
- 多变量logistic回归调整社会人口学因素、哮喘、食物过敏和季节性过敏后,AD与学习困难(AOR 1.77;95%CI 1.28-2.45)和记忆困难(AOR 1.69;95%CI 1.19-2.41)的 odds 增加相关。
- 按神经发育共病分层,合并任何神经发育障碍的AD儿童记忆困难AOR 2.26(95%CI 1.43-3.57),其中ADHD者AOR 2.90(95%CI 1.60-5.24),学习障碍者AOR 2.04(95%CI 1.04-4.00)。
- 无神经发育疾病的儿童中,AD与学习或记忆困难无显著关联。
临床怎么用
- 对AD儿童应关注认知困难症状,尤其合并ADHD或学习障碍者,可优先进行认知评估。
- 研究结果有助于对AD儿童认知障碍风险进行分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Previous studies suggest that atopic dermatitis (AD) is associated with cognitive impairment in children, but these studies have relied primarily on neurodevelopmental diagnoses (rather than symptoms) as proxy measures of cognitive function. It remains unknown if certain subpopulations of children with AD are at greater risk of cognitive impairment. OBJECTIVE: To examine the association of AD with symptoms of cognitive impairment (difficulty in learning or memory) among US children and whether this association varies according to the presence or absence of neurodevelopmental comorbidities (attention-deficit/hyperactivity disorder [ADHD], developmental delay, or learning disability). DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used 2021 data from the US National Health Interview Survey collected on children aged 17 years or younger without intellectual disability or autism. The presence of AD was based on a parent or adult caregiver's report indicating either a current diagnosis of AD or a previous medical confirmation of AD by a health care professional. MAIN OUTCOMES AND MEASURES: Difficulty with learning or memory as reported by the child's caregiver. RESULTS: Among the weighted total of 69 732 807 participants, 9 223 013 (13.2%) had AD. Compared with children without AD, children with AD were more likely to experience difficulties with learning (10.8% [95% CI, 7.8%-15.8%] vs 5.9% [95% CI, 5.1%-6.9%]; P < .001) and difficulties with memory (11.1% [95% CI, 8.0%-15.9%] vs 5.8% [95% CI, 4.9%-6.9%]; P < .001). In multivariable logistic regression models adjusted for sociodemographic factors, asthma, food allergies, and seasonal allergies or hay fever, AD was associated with increased odds of difficulties in learning (adjusted odds ratio [AOR], 1.77; 95% CI, 1.28-2.45) and memory (AOR, 1.69; 95% CI, 1.19-2.41). In analyses stratified by neurodevelopmental comorbidities, AD was associated with 2- to 3-fold greater odds of memory difficulties among children with any neurodevelopmental disorder (AOR, 2.26; 95% CI, 1.43-3.57), including ADHD (AOR, 2.90; 95% CI, 1.60-5.24) or learning disabilities (AOR, 2.04; 95% CI, 1.04-4.00). However, AD was not associated with learning or memory difficulties among children without neurodevelopmental conditions. CONCLUSIONS AND RELEVANCE: Results of this cross-sectional study suggest that pediatric AD was generally associated with greater odds of reported difficulties in learning and memory. However, this association was primarily limited to children with neurodevelopmental comorbidities, such as ADHD or learning disabilities. These findings may improve the risk stratification of children with AD for cognitive impairments and suggest that evaluation for cognitive difficulties should be prioritized among children with AD and neurodevelopmental disorders.
引用
- Ma EZ, Chang HR, Radtke S, et al. Symptoms of Cognitive Impairment Among Children With Atopic Dermatitis. JAMA Dermatol. 2024. PMID: 38446433. doi:10.1001/jamadermatol.2024.0015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。